1. Home
  2. LARK vs BIOA Comparison

LARK vs BIOA Comparison

Compare LARK & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LARK
  • BIOA
  • Stock Information
  • Founded
  • LARK 1885
  • BIOA 2015
  • Country
  • LARK United States
  • BIOA United States
  • Employees
  • LARK N/A
  • BIOA N/A
  • Industry
  • LARK Major Banks
  • BIOA Biotechnology: Pharmaceutical Preparations
  • Sector
  • LARK Finance
  • BIOA Health Care
  • Exchange
  • LARK Nasdaq
  • BIOA Nasdaq
  • Market Cap
  • LARK 135.9M
  • BIOA 139.1M
  • IPO Year
  • LARK N/A
  • BIOA 2024
  • Fundamental
  • Price
  • LARK $27.21
  • BIOA $3.78
  • Analyst Decision
  • LARK
  • BIOA Hold
  • Analyst Count
  • LARK 0
  • BIOA 4
  • Target Price
  • LARK N/A
  • BIOA $5.67
  • AVG Volume (30 Days)
  • LARK 24.6K
  • BIOA 158.3K
  • Earning Date
  • LARK 04-30-2025
  • BIOA 05-15-2025
  • Dividend Yield
  • LARK 3.08%
  • BIOA N/A
  • EPS Growth
  • LARK 6.33
  • BIOA N/A
  • EPS
  • LARK 2.26
  • BIOA N/A
  • Revenue
  • LARK $58,168,000.00
  • BIOA N/A
  • Revenue This Year
  • LARK N/A
  • BIOA N/A
  • Revenue Next Year
  • LARK N/A
  • BIOA N/A
  • P/E Ratio
  • LARK $12.00
  • BIOA N/A
  • Revenue Growth
  • LARK 3.55
  • BIOA N/A
  • 52 Week Low
  • LARK $17.05
  • BIOA $3.69
  • 52 Week High
  • LARK $28.55
  • BIOA $26.62
  • Technical
  • Relative Strength Index (RSI)
  • LARK 65.83
  • BIOA N/A
  • Support Level
  • LARK $26.75
  • BIOA N/A
  • Resistance Level
  • LARK $27.50
  • BIOA N/A
  • Average True Range (ATR)
  • LARK 1.04
  • BIOA 0.00
  • MACD
  • LARK 0.19
  • BIOA 0.00
  • Stochastic Oscillator
  • LARK 69.83
  • BIOA 0.00

About LARK Landmark Bancorp Inc.

Landmark Bancorp Inc is the bank holding company for Landmark National Bank, which is dedicated to providing quality financial and banking services. The bank is principally engaged in the business of attracting deposits from the general public and using such deposits, together with borrowings and other funds, to originate one-to-four-family residential real estate, construction and land, commercial real estate, commercial, agriculture, municipal and consumer loans. In addition, it also invests in certain investment and mortgage related securities using deposits and other borrowings as funding sources. Its primary deposit gathering and lending markets are geographically diversified with locations in central, eastern, southeast, and southwest Kansas.

About BIOA BioAge Labs Inc. Common Stock

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.

Share on Social Networks: